US approves Pfizer vaccine for ages 12-15

AAPAAP
VideoDr. Oz speaks to FOX 35 about the Pfizer coronavirus vaccine.

US regulators have authorised Pfizer and BioNTech’s COVID-19 vaccine for use in children as young as 12, widening the country’s inoculation program as vaccination rates have slowed significantly.

The vaccine has been available under an emergency use authorisation to people as young as 16 in the United States.

The vaccine makers said they had started the process for full approval for those ages last week.

The US Food and Drug Administration said it was amending the EUA to include the millions of children aged 12 to 15.

It’s the first COVID-19 vaccine to be authorised in the United States for this age group, seen as an important step for getting children back into schools safely.

AGED CARE VACCINATIONS
Camera IconSYDNEY, AUSTRALIA - NewsWire Photos FEBRUARY, 22, 2021: Residents are seen receiving their first dosage of the Pfizer COVID-19 vaccination at Uniting Banks Lodge Peakhurst Aged Care, in Sydney. Australia has begun its Pfizer COVID-19 vaccination rollout this morning, with hopes 60,000 doses will be administered by the end of the week. NCA NewsWire/Bianca De Marchi Credit: News Corp Australia

US President Joe Biden has asked states to make the vaccine available to the younger adolescents immediately.

Most children with COVID-19 only develop mild symptoms or no symptoms at all.

However, children are not without risk of becoming seriously ill, and they can still spread the virus. There have been outbreaks traced to sporting events and other activities for children in this age range.

Pfizer and BioNTech asked the FDA to expand their EUA to include the younger age group in early April.\

Nearly 46 per cent of people in the United States had received at least one shot of a COVID-19 vaccine as of Sunday, according to data from the US Centers for Disease Control and Prevention.

But the pace of US vaccinations has slowed significantly since topping out at a seven-day average of more than 3.3 million doses a day in mid-April.

That average had fallen by more than a third to about 2.1 million shots a day as of May 4.

Pfizer’s vaccine is the only one authorised for 16 and 17 year olds in the United States.

Nearly two million people in that age group have received at least one shot, according to CDC data.

Widely vaccinating 12- to 18-year olds could allow US schools to relax masking and social distancing measures suggested by the CDC.

Pfizer expects to have safety and efficacy data for children ages two to 11 in September, when it plans to ask for further expansion of the EUA for that age group.

Get the latest news from thewest.com.au in your inbox.

Sign up for our emails